Search research articles
Contact Us
Filters
Showing results (161-170 of 234) with videos related to
Page
of 24
Sort By:
Human Reproduction (Oxford, England)
|
June 12, 2004
Evidence of parthenogenetic origin of ovarian teratoma: case report
Flávio Garcia Oliveira, Dmitri Dozortsev, Michael Peter Diamond, et al.
Journal of Gastroenterology and Hepatology
|
September 17, 2013
MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis
Fanni Gelley, Gergely Zadori, Balazs Nemes, et al.
Nitric Oxide : Biology and Chemistry
|
December 23, 2014
The reaction products of sulfide and S-nitrosoglutathione are potent vasorelaxants
Andrea Berenyiova, Marian Grman, Ana Mijuskovic, et al.
The American Journal of Pathology
|
October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1
Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
The Journal of Pathology
|
December 28, 2016
The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization
Sándor Paku, Viktoria Laszlo, Katalin Dezso, et al.
Emerging Infectious Diseases
|
May 26, 2016
Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
Benjamin Meyer, Judit Juhasz, Rajib Barua, et al.
Emerging Infectious Diseases
|
August 21, 2020
Hepatitis E Virus Genotype 7 RNA and Antibody Kinetics in Naturally Infected Dromedary Calves, United Arab Emirates
Victor M Corman, Peter Nagy, Stefanie Ostermann, et al.
CNS Drugs
|
August 21, 2013
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study
Ralf W Dittmann, Esther Cardo, Peter Nagy, et al.
British Journal of Pharmacology
|
March 6, 2019
A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug
John L Wallace, Peter Nagy, Troy D Feener, et al.
Nature Biotechnology
|
January 6, 2004
Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction
Diane S Lidke, Peter Nagy, Rainer Heintzmann, et al.
Page
of 24
Search research articles
Search
Showing results (161-170 of 234) with videos related to
Sort By:
Page
of 24
Human Reproduction (Oxford, England)
|
June 12, 2004
Evidence of parthenogenetic origin of ovarian teratoma: case report
Flávio Garcia Oliveira, Dmitri Dozortsev, Michael Peter Diamond, et al.
Journal of Gastroenterology and Hepatology
|
September 17, 2013
MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis
Fanni Gelley, Gergely Zadori, Balazs Nemes, et al.
Nitric Oxide : Biology and Chemistry
|
December 23, 2014
The reaction products of sulfide and S-nitrosoglutathione are potent vasorelaxants
Andrea Berenyiova, Marian Grman, Ana Mijuskovic, et al.
The American Journal of Pathology
|
October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1
Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
The Journal of Pathology
|
December 28, 2016
The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization
Sándor Paku, Viktoria Laszlo, Katalin Dezso, et al.
Emerging Infectious Diseases
|
May 26, 2016
Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
Benjamin Meyer, Judit Juhasz, Rajib Barua, et al.
Emerging Infectious Diseases
|
August 21, 2020
Hepatitis E Virus Genotype 7 RNA and Antibody Kinetics in Naturally Infected Dromedary Calves, United Arab Emirates
Victor M Corman, Peter Nagy, Stefanie Ostermann, et al.
CNS Drugs
|
August 21, 2013
Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study
Ralf W Dittmann, Esther Cardo, Peter Nagy, et al.
British Journal of Pharmacology
|
March 6, 2019
A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug
John L Wallace, Peter Nagy, Troy D Feener, et al.
Nature Biotechnology
|
January 6, 2004
Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction
Diane S Lidke, Peter Nagy, Rainer Heintzmann, et al.
Page
of 24